vaccin
sarscov
infect
attract
mean
control
spread
virus
public
studi
employ
dna
vaccin
technolog
levamisol
newli
discov
chemic
adjuv
gener
type
respons
avoid
enhanc
antibodi
issu
gene
encod
nucleocapsid
membran
envelop
protein
sarscov
clone
express
mammalian
cell
determin
intramuscular
introduct
anim
observ
construct
e
n
gene
could
induc
high
level
specif
antibodi
cell
prolifer
ifnc
dth
respons
vivo
cytotox
cell
activ
specif
sarscov
antigen
highest
immun
respons
gener
construct
encod
nucleocapsid
protein
result
suggest
n
e
gene
could
use
target
prevent
sarscov
infect
dna
vaccin
develop
induct
type
respons
dna
vaccin
n
e
gene
sarscov
mice
q
sever
acut
respiratori
syndrom
sar
highli
contagi
diseas
caus
human
coronaviru
infect
sarscov
genom
sarscov
singlestrand
positivesens
rna
includ
cap
polyadenyl
structur
encod
five
major
protein
typic
coronavirus
includ
replic
polyprotein
spike
protein
envelop
protein
e
membran
glycoprotein
nucleocapsid
protein
n
develop
safe
yet
effect
sar
vaccin
new
challeng
laboratori
world
spike
protein
indic
key
protein
interact
cell
receptor
coronavir
famili
includ
sarscov
immun
spike
protein
kill
viral
vaccin
induc
enhanc
antibodi
acceler
subsequ
infect
felin
coronaviru
suggest
spike
protein
may
good
candid
antigen
use
vaccin
develop
e
two
protein
play
essenti
role
coronavir
particl
assembl
immun
respons
antigen
also
effect
inhibit
viral
infect
help
host
cell
induc
product
protect
ifna
viral
vaccin
design
much
attent
focus
induct
cell
respons
especi
gener
cytotox
lymphocyt
ctl
sever
studi
demonstr
protect
ctl
respons
induc
surfac
antigen
hbsag
viru
howev
report
shown
nucleocapsid
protein
good
target
induc
protect
ctl
respons
virus
ebola
influenza
measl
dna
vaccin
emerg
practic
technolog
gener
humor
cellular
immun
potenti
use
viral
infect
includ
human
immunodefici
viru
hepat
b
influenza
take
account
examin
immun
respons
gener
dna
vaccin
encod
n
e
protein
sarscov
mice
three
dna
vaccin
induc
potent
polar
immun
respons
well
specif
antibodi
anim
highest
level
humor
respons
cell
prolifer
activ
induc
n
gene
construct
also
observ
vivo
ctl
activ
success
induc
mice
dna
construct
anim
femal
balbc
mice
week
old
purchas
beij
vital
laboratori
anim
technolog
beij
china
randomli
divid
group
per
group
receiv
pathogenfre
water
food
mainten
viru
isol
femal
patient
hospit
confirm
diagnosi
infect
sarscov
sarscov
isol
establish
infect
vero
cell
filter
stool
sampl
patient
condit
cytopath
effect
observ
cultur
cdna
gener
rna
isol
supernat
cultur
use
sequenc
analysi
confirm
sarscov
ident
plasmid
construct
immun
dna
vaccin
construct
encod
e
protein
glycoprotein
n
protein
sarscov
obtain
follow
gene
amplifi
cdna
pcr
amplif
use
set
specif
primer
respect
n
gene
upstream
primer
downstream
one
aagaattcgtttatgcctgagttg
gene
upstream
primer
aa
gaattcgccatggca
downstream
one
aatct
agattactgtactagcaaagcaat
e
gene
upstream
primer
aa
gaattcgccatgtactcatt
downstream
one
aatctagatta
express
three
gene
eukaryot
cell
sequenc
contain
atg
start
codon
kozak
consensu
sequenc
gcc
incorpor
end
upstream
primer
restrict
digest
site
also
incorpor
primer
indic
underlin
amplifi
product
first
clone
vector
confirm
sequenc
analysi
respect
three
product
respect
subclon
appropri
site
kb
eukaryot
express
vector
deriv
vector
invitrogen
delet
region
promot
neomycin
orf
poli
final
product
design
respect
three
dna
vaccin
transform
escherichia
coli
strain
invitrogen
extract
purifi
precipit
final
product
dissolv
salin
solut
store
immun
determin
express
dna
construct
hela
cell
seed
cell
per
plate
cm
plate
contain
complet
dmem
supplement
fetal
bovin
serum
gibcobrl
cell
cultur
humidifi
incub
co
confluent
three
construct
transfect
hela
cell
use
lipofectamin
accord
instruct
invitrogen
ca
usa
respect
total
cellular
rna
extract
harvest
cell
use
extract
kit
sangon
shanghai
china
h
transfect
cdna
synthes
total
rna
reaction
system
consist
revers
transcriptas
buffer
mm
trishcl
ph
mm
kcl
mm
mgcl
mm
dtt
pmol
oligo
dt
primer
mm
dntp
u
amv
revers
transcriptas
u
rnase
inhibitor
reaction
perform
min
min
rna
deriv
hela
cell
transfect
control
vector
process
parallel
neg
control
cdna
amplifi
pcr
pair
sarscovspecif
primer
describ
cycl
extens
min
last
cycl
pcr
product
load
agaros
gel
visual
nm
uv
light
immun
immun
dna
construct
mix
levamisol
lm
adjuv
final
inject
accord
previou
studi
mous
inject
dna
vaccin
intramuscularli
twice
biweekli
interv
mice
sera
collect
regularli
day
store
later
use
detect
antisarscov
antibodi
serum
antisarscov
antibodi
level
assay
enzymelink
immunosorb
assay
elisa
ninetysix
well
microtit
plate
coat
lgml
chemic
kill
sarscov
antigen
per
well
dilut
bicarbon
buffer
ph
overnight
follow
block
well
bsapbst
h
mous
serum
serial
dilut
ad
well
incub
h
secondari
goat
antimous
antibodi
conjug
horseradish
peroxidas
sigma
st
loui
il
ad
well
incub
h
develop
elisa
mg
tmb
tablet
sigma
st
loui
dissolv
ml
phosphatecitr
buffer
result
solut
ad
well
reaction
stop
addit
h
result
optic
densiti
od
nm
analyz
plate
reader
magellan
tecan
austria
gmbh
titer
valu
assign
highest
dilut
optic
densiti
sd
higher
od
produc
serum
preimmun
mice
equival
dilut
cell
prolifer
activ
day
second
inject
mice
sacrif
singlecel
suspens
prepar
spleen
group
describ
previous
splenocyt
cultur
triplic
microtit
plate
cell
per
well
cultur
respect
stimul
h
follow
lgml
con
posit
control
lgml
chemic
kill
sarscov
specif
antigen
lgml
bsa
irrelev
antigen
none
neg
control
cell
incub
co
h
colorimetr
reaction
perform
accord
cell
titer
aqueou
nonradioact
cell
prolifer
assay
protocol
promega
usa
briefli
cell
mix
mixtur
mtspm
well
cultur
h
od
valu
quantit
read
absorb
nm
plate
reader
magellan
tecan
austria
gmbh
stimul
index
si
determin
mean
od
read
triplic
antigen
contain
well
divid
mean
od
read
triplic
well
without
antigen
antigenspecif
dth
five
mice
group
test
dth
respons
seven
day
second
immun
mice
challeng
chemic
kill
sarscov
right
footpad
also
receiv
inject
salin
solut
left
footpad
control
thick
footpad
measur
h
later
micromet
vivo
ctl
assay
vivo
cytotox
assay
recent
document
briefli
prepar
target
cell
detect
vivo
cytotox
activ
splenocyt
isol
balbc
spleen
erythrocyt
remov
singl
suspens
cell
wash
equal
split
two
part
one
puls
chemic
kill
sarscov
lgml
h
label
high
concentr
cfse
lm
molecular
probe
portland
usa
design
cfse
high
cell
control
target
label
low
concentr
cfse
lm
design
cfse
low
cell
two
popul
cell
mix
togeth
inject
intraven
cell
mous
previous
immun
e
n
control
dna
construct
day
earlier
mous
sacrif
h
later
isol
lymph
node
cell
suspens
lymph
node
analyz
facscalibur
analyz
bd
bioscienc
mountain
view
ca
popul
detect
via
differenti
cfse
fluoresc
intens
calcul
specif
lysi
follow
formula
use
ratio
percentag
cfse
low
percentag
cfse
high
percentagespecif
lysi
ratio
unprimedratio
prime
cytokin
assay
rel
amount
cytokin
level
determin
semiquantit
rtpcr
known
amount
competitor
pqr
previous
describ
extract
kit
sangon
shanghai
china
use
extract
total
rna
cdna
synthes
amv
revers
transcriptas
oligo
dt
primer
pcr
optim
specif
primer
housekeep
cytokin
gene
describ
previous
amount
specif
competitor
product
reaction
assess
scan
imag
ethidium
bromidestain
gel
use
biorad
imag
softwar
quantiti
one
total
volum
intensityarea
specif
product
determin
statist
analysi
perform
statist
analysi
statist
analysi
perform
use
test
onesid
differ
consid
statist
signific
p
identif
three
construct
analyz
restrict
digest
confirm
sequenc
analysi
data
shown
order
confirm
dna
construct
e
express
e
n
protein
eukaryot
system
construct
transfect
confluent
hela
cell
total
rna
extract
cell
h
transfect
use
perform
rtpcr
assay
detect
presenc
e
n
mrna
pair
specif
primer
target
band
observ
cell
transfect
construct
wherea
band
similar
size
detect
vector
control
transfect
cell
fig
result
suggest
three
dna
construct
encod
e
n
protein
success
express
eukaryot
cell
examin
humor
respons
mice
level
antisarscovspecif
antibodi
mice
immun
respect
determin
elisa
sera
day
determin
titer
specif
igg
shown
fig
three
construct
induc
significantli
higher
level
sarscovspecif
antibodi
control
group
immun
vector
moreov
among
inocul
induc
highest
specif
antibodi
titer
sarscov
determin
cell
prolif
respons
singl
suspens
splenocyt
prepar
mice
spleen
day
second
immun
perform
cell
prolifer
assay
fig
show
highest
stimul
index
achiev
cell
isol
spleen
fig
lymph
node
fig
mice
inject
level
prolif
respons
mice
immun
significantli
higher
anim
immun
vector
control
sinc
dth
reflect
antigenspecif
cell
activ
prolifer
vivo
antigensensit
anim
react
site
challeng
antigen
next
evalu
whether
sarscovdepend
dth
could
also
induc
three
dna
vaccin
day
second
immun
group
mice
challeng
chemic
kill
sarscov
right
footpad
salin
solut
left
footpad
neg
control
thick
footpad
measur
h
challeng
tabl
observ
group
mice
inject
show
highest
level
dth
follow
group
immun
construct
specif
ctl
activ
demonstr
import
factor
control
viral
infect
previous
mani
studi
access
ctl
activ
perform
vitro
system
may
directli
reflect
situat
vivo
detect
presenc
antisarscovspecif
ctl
vivo
adopt
method
previous
document
target
splenocyt
differenti
label
csfe
transfer
immun
control
mous
intraven
specif
antigenlabel
target
cell
kill
antigen
unlabel
target
would
surviv
fig
show
degre
specif
lysi
achiev
target
cell
isol
lymph
node
h
transfer
immun
syngen
host
specif
lysi
target
cell
fig
observ
mice
immun
construct
inject
construct
fig
group
inject
construct
fig
data
suggest
mice
vaccin
n
construct
produc
highest
ctl
activ
vivo
conclud
previou
result
n
gene
contain
immunogenet
region
b
cell
stimul
demonstr
better
immunogen
gener
n
gene
profil
cytokin
may
lead
understand
signific
measur
rel
level
cytokin
rna
sampl
compet
amount
competitor
pqr
pgml
show
express
housekeep
gene
fig
antibodi
respons
sarscov
mice
five
per
group
bled
day
initi
immun
mean
titer
standard
deviat
sd
antibodi
five
anim
cov
evalu
elisa
lgml
chemic
kill
sarscov
antigen
coat
well
plate
use
absolut
ratio
serum
cutoff
indic
valu
statist
signific
p
valu
test
compar
group
control
vector
hprt
allow
semiquantit
comparison
made
group
rna
use
rtpcr
initi
normal
accord
level
express
level
hprt
depict
fig
show
highest
level
mrna
ifnc
induc
group
immun
construct
suggest
polar
respons
follow
group
immun
construct
cytokin
mrna
express
observ
immun
n
dna
vaccin
express
observ
except
group
inject
gene
construct
dna
vaccin
receiv
consider
attent
due
abil
induc
humor
cellular
immun
respons
induc
immun
respons
case
even
lead
protect
variou
type
infect
influenza
malaria
sar
common
featur
dna
vaccin
synthesi
antigen
occur
intracellular
compart
allow
process
antigen
enter
mhc
class
pathway
turn
gener
ctl
activ
report
demonstr
humoraland
cellularmedi
specif
respons
could
induc
dna
construct
encod
n
e
antigen
sarscov
three
dna
construct
induc
sarscovspecif
antibodi
mice
group
show
highest
titer
antibodi
follow
group
group
fig
addit
cell
prolifer
dth
respons
also
success
induc
mice
vaccin
construct
fig
tabl
result
suggest
dna
vaccin
effect
prime
specif
antisarscov
respons
appar
gener
broad
rang
thelper
bcell
memori
prime
also
consist
previou
observ
protect
immun
furthermor
administr
dna
gener
lower
level
fig
suggest
role
dna
initi
polar
immun
vaccin
design
much
attent
focus
induct
cell
respons
especi
antigenspecif
ctl
sever
studi
found
nucleocapsid
protein
could
induc
ctl
respons
case
human
hantaan
viru
lethal
coronaviru
periton
viru
recent
zhu
et
al
found
dna
construct
base
vector
could
success
induc
sarscov
n
proteinspecif
immun
respons
manner
induc
high
antibodi
titer
ctl
respons
kim
demonstr
vaccin
n
dna
vaccin
could
success
induc
sarscov
antigenspecif
cell
respons
distinctli
reduc
titer
recombin
vaccinia
viru
express
sarscov
n
protein
challeng
coexpress
calreticulin
crt
kda
ca
bind
protein
n
gene
could
enhanc
abil
protect
viral
challeng
present
studi
consist
work
n
protein
construct
could
induc
highest
sarsspecif
igg
cell
prolifer
vivo
ctl
respons
lysi
rate
compar
protein
gene
lysi
rate
e
protein
gene
lysi
rate
fig
furthermor
highest
type
respons
base
express
ifnc
also
induc
n
protein
howev
higher
level
immun
respons
gener
vaccin
may
due
epitop
n
nucleocapsid
protein
sinc
contain
amino
acid
residu
protein
amino
acid
e
amino
acid
addit
differenti
concentr
antigen
present
kill
sarscov
prepar
could
also
contribut
differ
specif
ctl
activ
demonstr
import
factor
confront
viru
infect
previous
document
monkey
vaccin
dna
vaccin
encod
gag
protein
nuclear
protein
induc
specif
ctl
monkey
thu
confer
partial
protect
challeng
shiv
simianhuman
immunodefici
viru
access
ctl
vivo
situat
three
dna
vaccin
test
studi
indic
high
level
ctl
gener
sarscovlabel
target
cell
whether
vivo
ctl
could
control
sarscov
infect
need
investig
well
known
protect
immun
viral
infect
associ
induct
immun
respons
product
antigenspecif
ifnc
splenocyt
augment
significantli
vaccin
three
dna
construct
compar
vector
control
group
receiv
immun
induc
highest
level
ifnc
shown
fig
consist
highest
level
antigenspecif
cell
activ
shown
fig
dth
respons
mice
shown
tabl
summari
administr
three
sarscov
dna
vaccin
studi
abl
induc
high
level
antigenspecif
igg
antibodi
cell
prolifer
ifnc
dth
vivo
ctl
respons
suggest
type
respons
induc
three
structur
gene
sarscov
dna
vaccin
may
lead
desir
mean
therapeut
approach
sarscov
infect
consid
fig
semiquantit
rtpcr
assay
cytokin
gene
express
total
rna
isol
spleen
immun
group
normal
mice
group
level
cytokin
ifnc
semiquantit
measur
competit
rtpcr
addit
pgml
pqr
competitor
normal
test
cdna
concentr
constant
amount
hprt
describ
materi
method
